BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33093279)

  • 1. Almitrine Infusion in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
    Caplan M; Goutay J; Bignon A; Jaillette E; Favory R; Mathieu D; Parmentier-Decrucq E; Poissy J; Duburcq T;
    Crit Care Med; 2021 Feb; 49(2):e191-e198. PubMed ID: 33093279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome.
    Jolliet P; Bulpa P; Ritz M; Ricou B; Lopez J; Chevrolet JC
    Crit Care Med; 1997 May; 25(5):786-94. PubMed ID: 9187597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response curves of inhaled nitric oxide with and without intravenous almitrine in nitric oxide-responding patients with acute respiratory distress syndrome.
    Lu Q; Mourgeon E; Law-Koune JD; Roche S; Vézinet C; Abdennour L; Vicaut E; Puybasset L; Diaby M; Coriat P
    Anesthesiology; 1995 Nov; 83(5):929-43. PubMed ID: 7486178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nitric oxide, almitrine infusion, or their coadministration as a treatment of severe hypoxemic focal lung lesions.
    Paven D; Muret J; Beloucif S; Gatecel C; Kermarrec N; Guinard N; Mateo J
    Anesthesiology; 1998 Nov; 89(5):1157-65. PubMed ID: 9822004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular response to high-dose almitrine infusion in patients with severe hypoxemia related to acute respiratory distress syndrome.
    Michard F; Wolff MA; Herman B; Wysocki M
    Crit Care Med; 2001 Jan; 29(1):32-6. PubMed ID: 11176154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of almitrine as a rescue therapy for refractory hypoxemia in COVID and non-COVID acute respiratory distress syndrome. A retrospective monocenter study.
    Blot PL; DE Roquetaillade C; Deniau B; Gaugain S; Kindermans M; Julian N; LE Dorze M; Mebazaa A; Chousterman BG; Barthélémy R
    Minerva Anestesiol; 2023 Mar; 89(3):157-165. PubMed ID: 36287391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19.
    Laghlam D; Rahoual G; Malvy J; Estagnasié P; Brusset A; Squara P
    Front Med (Lausanne); 2021; 8():655763. PubMed ID: 34277653
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of almitrine in spontaneously breathing patients with COVID-19 treated with high-flow nasal cannula oxygen therapy and with persistent hypoxemia.
    Saccheri C; Morand L; Juston M; Doyen D; Hyvernat H; Lombardi R; Devanlay R; Panicucci É; Dellamonica J; Jozwiak M
    Respir Res; 2023 Jan; 24(1):1. PubMed ID: 36600234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Almitrine Infusion During Veno-Venous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome in Adults.
    Esnault P; Hraiech S; Bordes J; Forel JM; Adda M; Rambaud R; Lehingue S; Roch A; Papazian L; Guervilly C
    Anesth Analg; 2019 Aug; 129(2):e48-e51. PubMed ID: 29337729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome. The NO Almitrine Study Group.
    Gallart L; Lu Q; Puybasset L; Umamaheswara Rao GS; Coriat P; Rouby JJ
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1770-7. PubMed ID: 9847266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prone Position in COVID-19 and -COVID-19 Acute Respiratory Distress Syndrome: An International Multicenter Observational Comparative Study.
    Camporota L; Sanderson B; Chiumello D; Terzi N; Argaud L; Rimmelé T; Metuor R; Verstraete A; Cour M; Bohé J; Piriou V; Beuret P; Guérin C
    Crit Care Med; 2022 Apr; 50(4):633-643. PubMed ID: 34582426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled NO and almitrine bismesylate in patients with acute respiratory distress syndrome: effect of noradrenalin.
    Papazian L; Bregeon F; Gaillat F; Thirion X; Roch A; Cortes E; Fulachier V; Saux P; Jammes Y; Auffray JP
    Eur Respir J; 1999 Dec; 14(6):1283-9. PubMed ID: 10624756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome.
    Wysocki M; Delclaux C; Roupie E; Langeron O; Liu N; Herman B; Lemaire F; Brochard L
    Intensive Care Med; 1994; 20(4):254-9. PubMed ID: 8046118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High or low doses of almitrine bismesylate in ARDS patients responding to inhaled NO and receiving norepinephrine?
    Roch A; Papazian L; Bregeon F; Gainnier M; Michelet P; Thirion X; Saux P; Thomas P; Jammes Y; Auffray JP
    Intensive Care Med; 2001 Nov; 27(11):1737-43. PubMed ID: 11810116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
    Bendjelid K; Giraud R; Von Düring S
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
    [No Abstract]   [Full Text] [Related]  

  • 16. Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome.
    Bagate F; Tuffet S; Masi P; Perier F; Razazi K; de Prost N; Carteaux G; Payen D; Mekontso Dessap A
    Ann Intensive Care; 2020 Nov; 10(1):151. PubMed ID: 33150525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the effects of almitrine bismesylate and lateral position during unilateral bacterial pneumonia with severe hypoxemia.
    Dreyfuss D; Djedaini K; Lanore JJ; Mier L; Froidevaux R; Coste F
    Am Rev Respir Dis; 1992 Aug; 146(2):295-9. PubMed ID: 1489115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.
    Cardinale M; Esnault P; Cotte J; Cungi PJ; Goutorbe P
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):471-472. PubMed ID: 32505755
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doppler study of the effects of inhaled nitric oxide and intravenous almitrine on regional pulmonary blood flows in patients with acute lung injury.
    Bouhemad B; Barbry T; Soummer A; Lu Q; Rouby JJ
    Minerva Anestesiol; 2014 May; 80(5):517-25. PubMed ID: 24299918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.